Safety and efficacy of COVID-19 vaccines in people with neurological disorders
- PMID: 34887547
- PMCID: PMC8655711
- DOI: 10.1038/s41582-021-00603-8
Safety and efficacy of COVID-19 vaccines in people with neurological disorders
Comment on
-
COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China.Epilepsia. 2022 Jan;63(1):244-251. doi: 10.1111/epi.17138. Epub 2021 Nov 21. Epilepsia. 2022. PMID: 34806164 Free PMC article.
-
mRNA intramuscular vaccination produces a robust IgG antibody response in advanced neuromuscular disease.Neuromuscul Disord. 2022 Jan;32(1):33-35. doi: 10.1016/j.nmd.2021.11.006. Epub 2021 Nov 19. Neuromuscul Disord. 2022. PMID: 34920929 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources